Posted by Michael Wonder on 28 May 2018
Medicines have prices slashed from June
27 May 2018 - The Turnbull government is subsidising a range of life-changing medicines from June 1, including one for chronic lung disease.
More than half-a-million Australians with severe breathing difficulties from chronic lung disease will have the price of a life-changing drug slashed.
Australians with type 2 diabetes will also have access to Trulicity for less than $40 a script from June 1, saving patients about $1700 per year.
Simponi will be listed for Australians suffering from ulcerative colitis, saving them around $15,800 per year.
While about 500 patients with Stage IV clear cell variant renal cell carcinoma will be able to access Cabometyx, which without the subsidy would cost around $129,800 a year.
